Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"CYCORE: Cyberinfrastructure for Comparative Effectiveness Research - Feasibility Trial"

NCT01365169 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT01365169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01365169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"CYCORE: Cyberinfrastructure for Comparative Effectiveness Research - Feasibility Trial"
Lead sponsor
M.D. Anderson Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
May 25, 2011
Completion date
June 30, 2027
Enrollment
590 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant head and neck neoplasm, malignant neoplasm, metastatic malignant neoplasm in the neck, metastatic malignant neoplasm in the uterine cervix, metastatic or locally unresectable solid tumor, pancreatic adenocarcinoma, pancreatic neuroendocrine carcinoma, recurrent colorectal carcinoma, stage i colorectal cancer ajcc v6 and v7, stage i hypopharyngeal carcinoma ajcc v7, stage i major salivary gland cancer ajcc v7, stage i nasopharyngeal carcinoma ajcc v7, stage i oral cavity cancer ajcc v6 and v7, stage i oropharyngeal carcinoma ajcc v6 and v7, stage ii colorectal cancer ajcc v7, stage ii hypopharyngeal carcinoma ajcc v6 and v7, stage ii major salivary gland cancer ajcc v7, stage ii nasopharyngeal carcinoma ajcc v7, stage ii oral cavity cancer ajcc v6 and v7, stage ii oropharyngeal carcinoma ajcc v6 and v7, stage iia colorectal cancer ajcc v7, stage iib colorectal cancer ajcc v7, stage iic colorectal cancer ajcc v7, stage iii colorectal cancer ajcc v7, stage iii hypopharyngeal carcinoma ajcc v7, stage iii laryngeal cancer ajcc v6 and v7, stage iii major salivary gland cancer ajcc v7, stage iii nasopharyngeal carcinoma ajcc v7, stage iii oral cavity cancer ajcc v6 and v7, stage iii oropharyngeal carcinoma ajcc v7, stage iiia colorectal cancer ajcc v7, stage iiib colorectal cancer ajcc v7, stage iiic colorectal cancer ajcc v7, stage iv colorectal cancer ajcc v7, stage iva colorectal cancer ajcc v7, stage iva hypopharyngeal carcinoma ajcc v7, stage iva laryngeal cancer ajcc v7, stage iva major salivary gland cancer ajcc v7, stage iva nasopharyngeal carcinoma ajcc v7, stage iva oral cavity cancer ajcc v6 and v7, stage iva oropharyngeal carcinoma ajcc v7, stage ivb colorectal cancer ajcc v7, stage ivb hypopharyngeal carcinoma ajcc v7, stage ivb laryngeal cancer ajcc v7, stage ivb major salivary gland cancer ajcc v7, stage ivb nasopharyngeal carcinoma ajcc v7, stage ivb oral cavity cancer ajcc v6 and v7, stage ivb oropharyngeal carcinoma ajcc v7